FindTrial
Sign In

Detection of tumors in the gall bladder using Ultrasound and Computed Tomography.

Role of Ultasonography and Computed Tomography in gall bladder masses and their correlation with Cytopathology. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/07/055268
Enrollment
50
Registered
2023-07-17
Start date
Unknown
Completion date
Unknown
Last updated
2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C23- Malignant neoplasm of gallbladder

Interventions

Intervention1: Nil: Nil Control Intervention1: Nil: Nil

Sponsors

Dr Shubham Sharma
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients who have undergone Ultrasonography (USG) and Contrast Enhanced Computed Tomography (CECT) abdomen followed by Cyto-pathological examination for GB mass lesions.

Exclusion criteria

Exclusion criteria: 1. Patients coming with any of the three evaluating modality which are Ultrasonography, Computed Tomography and Fine Needle Aspiration Cytology done outside. 2. Patients under age of 20 and above 90 will be excluded.

Design outcomes

Primary

MeasureTime frame
Gall bladder mass lesion.Timepoint: 1 week, 4 weeks—

Secondary

MeasureTime frame
Correlating gall bladder mass lesions with cyto-pathology.Timepoint: 8 weeks, 12 weeks—

Countries

India

Contacts

Public ContactShubham Sharma

Varun Arjun Medical College and Rohilkhand Hospital

drshubhamdrpktiwariradiology@gmail.com9044484353

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026